Clinical Trials Browser

Phase 1/2 × Interventional × trastuzumab duocarmazine × Clear all

NCT04983238 2024-01-05

Evaluation of Safety and Efficacy of Sodium Thiosulfate (BYON5667) Eye Drops to Reduce Ocular Toxicity in Cancer Patients Treated With SYD985

Phase 1/2 Completed

Breast Neoplasms